Upcoming Federal Elections Will Significantly Impact 340B Legislative Agenda, Say 340B Hospital Lobbyist, Drug Industry Analyst

Tom O’Donnell, senior vice president of government relations at 340B Health, and Michael McCaughan, co-founder of Provision Policy, gave a July 10 address at the 340B Coalition summer conference.
The upcoming U.S. presidential and congressional elections will significantly alter the direction of 340B and broader healthcare policy, a 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Advocates March on Capitol Hill to ‘Defend 340B’ Amid D.C. Heat Wave

More than 60 advocates marched on Capitol Hill amid a heat wave in Washington, D.C. for the third annual "Defend 340B March" on July 10.
More than sixty 340B advocates braved an excessive heat warning in the nation’s capital yesterday afternoon for the third annual [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Navigating State-Level Regulations to Safeguard Your 340B Program

SPONSORED CONTENT

While federal laws and regulations set the foundation for 340B compliance, state-level laws introduce an additional layer of complexity. Covered entities (CEs) must be vigilant in understanding how these state laws can impact their operations to avoid potential compliance pitfalls. We have outlined a few

Read More »

Matsui’s 340B PATIENTS Act Gains 5 Democratic Co-Sponsors Ahead of 340B Health Lobby Days

U.S. Capitol building at sunrise
Five congressional Democrats signed on as co-sponsors to a bill that would bar drugmaker restrictions on 340B contract pharmacy arrangements.
As hospital advocates prepared to begin their annual summer visits to Capitol Hill this week, five congressional Democrats signed on [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Pharma-Linked Conservative Nonprofit Launches Ad Campaign to ‘Stop the Feeding Frenzy’ in 340B

The Council for Citizens Against Government Waste has launched a new ad campaign that criticizes the 340B program.
An anti-government waste group with ties to the drug industry is urging lawmakers to “stop the feeding frenzy” in the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drug Industry Takes Issue with IRA’s Drug Negotiation Guidance

PhRMA recently urged CMS to establish a neutral clearinghouse and require accurate use of 340B claim modifiers to address nonduplication in its final guidance for Medicare drug price negotiations under the IRA.
Editor’s Note: In Tuesday’s issue, we looked at comments from 340B provider stakeholders, today we look more closely at the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

New Hampshire Enacts Law to Bar PBMs, Payers from ‘Discriminating Against’ 340B Providers

New Hampshire Gov. Chris Sununu (R) signed a law prohibiting certain 340B-specific policies by PBMs and payers.
New Hampshire Gov. Chris Sununu (R) yesterday signed a law prohibiting payers and pharmacy benefit managers (PBMs) from “discriminating against [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Apotex to Issue Refunds to 340B Covered Entities 

Apotex Corp. announced in a July 2 notice to 340B providers that it will issue refunds to 340B covered entities that purchased any of nearly 400 products.
A Canadian drug manufacturer recently announced that it will refund covered entities for hundreds of different products purchased between 2021 [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Providers Take Issue with CMS Draft Guidance on IRA Implementation Calling It “Problematic, Unworkable and Inconsistent”

340B provider groups strongly criticized the Centers for Medicare & Medicaid Services’ draft guidance for Medicare drug price negotiations.
Editor’s Note: In today’s issue, we look at the 340B provider community’s comments to CMS. In a future issue, we [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Astellas Suspends its Contract Pharmacy Restrictions in More States; BMS and Sanofi Also Announce State Exemptions

Astellas building mounted sign
Astellas Pharma announced the suspension of its contract pharmacy policy in Maryland and Mississippi.
A Japanese drug manufacturer has ended its 340B contract pharmacy restrictions in Maryland and Mississippi in conjunction with new contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live